You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple-class Refractory Multiple Myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn How Triple Class Refractory Multiple Myeloma Are Treated

Not yet recruiting
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
    • (no location specified)
    Feb 15, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Jacksonville (Belantamab Mafodotin, Biospecimen

    Not yet recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Belantamab Mafodotin
    • +6 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Apr 27, 2023

    Multiple Myeloma, Refractory Trial in Washington, Hackensack, Neptune (Pembrolizumab, Belantamab mafodotin, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma, Refractory
    • Washington, District of Columbia
    • +2 more
    Aug 5, 2022

    Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

    Recruiting
    • Multiple Myeloma, Refractory
    • Patra, Achaia, Greece
    • +15 more
    Apr 4, 2022

    Medicine Called Elranatamab in People With Relapsed Refractory

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Jun 30, 2023

    Quality of Life in Relapsed and/or Refractory Multiple Myeloma

    Active, not recruiting
    • Multiple Myeloma
      • Morrisville, North Carolina
        Local Institution
      May 12, 2022

      Learn About Medicine in People With Relapsed Refractory Multiple

      Completed
      • Multiple Myeloma
      • New York, New York
        Pfizer
      Nov 14, 2022

      Relapsed and/or Refractory Multiple Myeloma Trial in United States (Melphalan Flufenamide, Dexamethasone)

      Approved for marketing
      • Relapsed and/or Refractory Multiple Myeloma
      • Springdale, Arkansas
      • +10 more
      Mar 16, 2021

      Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

      Recruiting
      • Elranatamab
      • +10 more
      • Fuzhou, Fujian, China
      • +18 more
      Jan 18, 2023

      Patients With Relapsed/Refractory Multiple Myeloma

      Not yet recruiting
      • Relapsed and Refractory Multiple Myeloma (RRMM)
      • Non-Interventional
      • (no location specified)
      Dec 21, 2022

      Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

      Withdrawn
      • Relapsed Multiple Myeloma
      • Refractory Multiple Myeloma
      • Elotuzumab, Selinexor, and Dexamethasone (ESd)
      • (no location specified)
      Apr 27, 2022

      Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

      Not yet recruiting
      • Multiple Myeloma in Relapse
      • Multiple Myeloma, Refractory
      • (no location specified)
      Oct 30, 2023

      Multiple Myeloma, Myeloma, Myeloma Multiple Trial in United States (KTX-1001)

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Scottsdale, Arizona
      • +5 more
      Jan 12, 2023

      Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

      Not yet recruiting
      • Relapsed and/or Refractory Multiple Myeloma
      • Köln, Germany
        Local Institution - 0017
      Dec 4, 2023

      Multiple Myeloma Trial (AZD0305)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Oct 24, 2023

      Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

      Not yet recruiting
      • Refractory Multiple Myeloma
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Nov 17, 2023

      Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)

      Not yet recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Suzhou, Jiangsu, China
        First Affiliated Hospital, Soochow University
      Jul 31, 2023

      Multiple Myeloma Trial (CM313 injection)

      Not yet recruiting
      • Multiple Myeloma
      • CM313 injection
      • (no location specified)
      Nov 6, 2023

      Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

      Recruiting
      • Relapse/Refractory Multiple Myeloma
      • DeepTag-GPRC5D Targeted CAR T-cells
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Oct 10, 2023

      Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

      Not yet recruiting
      • Relapsed/Refractory Multiple Myeloma
      • ISB 2001
      • Benowa, Queensland, Australia
        Pindara Private Hospital
      May 18, 2023

      Relapsed or Refractory Multiple Myeloma Trial in Tianjin (YTS104 Cells injection)

      Not yet recruiting
      • Relapsed or Refractory Multiple Myeloma
      • YTS104 Cells injection
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jun 13, 2023

      Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma Trial in Boston (Isatuximab, Belantamab mafodotin, Pomalidomide)

      Not yet recruiting
      • Relapsed Cancer
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Jun 19, 2023

      Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

      Not yet recruiting
      • Relapsed or Refractory Multiple Myeloma
      • (no location specified)
      Sep 20, 2023

      Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)

      Terminated
      • Myeloma Multiple
      • +2 more
      • Brooklyn, New York
      • +1 more
      Jan 24, 2023

      Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

      Not yet recruiting
      • Relapsed/ Refractory Multiple Myeloma
      • GC012F
      • (no location specified)
      Apr 28, 2023